Number of the records: 1
proteíny fúzne, bcr-abl
SYS d016044 LBL 00000cz--a2200000n--4500 005 20250606213127.7 008 920525|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 065 $a D08.811.913.696.620.682.725.500.500 065 $a D12.776.476.568.500.500 065 $a D12.776.602.500.500.100 065 $a D12.776.624.664.500.100 065 $a D12.776.624.664.700.171.500 066 $a 01 $c 03 150 $a proteíny fúzne, bcr-abl $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a bcr-abl Fusion Protein $2 eng 450 $w v $a bcr-abl Fusion Proteins $2 eng 450 $w v $a Oncogene Protein p190(bcr-abl) $2 eng 450 $w v $a Oncogene Protein p210(bcr-abl) $2 eng 450 $w v $a bcr-abl tyrozínkináza $2 slo 450 $w v $a proteín onkogénový p185(bcr-abl) $2 slo 450 $w v $a proteín onkogénový p190(bcr-abl) $2 slo 450 $w v $a proteín onkogénový p210(bcr-abl) $2 slo 450 $w v $a proteín onkogénový p230(bcr-abl) $2 slo 450 $w v $a tyrozín kináza bcr-abl $2 slo 450 $w v $a bcr-abl fúzny proteín $2 slo 450 $w v $a bcr-abl fúzne proteíny $2 slo 450 $w v $a proteíny fúzne p185(bcr-abl) $2 slo 450 $w v $a proteíny fúzne p190(bcr-abl) $2 slo 450 $w v $a proteíny fúzne p210(bcr-abl) $2 slo 450 $w v $a proteíny fúzne p230(bcr-abl) $2 slo 550 $7 sllk_us_auth*d010677 $Y Philadelphia Chromosome $w p $a chromozóm Philadelphia 550 $7 sllk_us_auth*d016313 $Y Genes, abl $w b $a gény abl 550 $7 sllk_us_auth*d016315 $Y Proto-Oncogene Proteins c-abl $w b $a proteíny protoonkogénové c-abl 665 $a 91; was BCR-ABL FUSION PROTEINS 1990 $2 eng 665 $a Neoplasm Proteins (1986-1989) $2 eng 680 9-
$i Translation products of a fusion gene derived from CHROMOSOMAL TRANSLOCATION of C-ABL GENES to the genetic locus of the breakpoint cluster region gene on chromosome 22. Several different variants of the bcr-abl fusion proteins occur depending upon the precise location of the chromosomal breakpoint. These variants can be associated with distinct subtypes of leukemias such as PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; and NEUTROPHILIC LEUKEMIA, CHRONIC. $2 eng 750 -2
$a Fusion Proteins, bcr-abl $2 eng 980 $x M
Number of the records: 1